Dissemination

Physician’s Weekly recently spoke with Brooks Cash, MD about NHE3 inhibitors and their unique method of action (MOA) in treating patients with IBS-C.

Physician’s Weekly recently spoke with Satish SC Rao, MD, PhD, FRCP, FACG, AGAF about NHE3 inhibitors and their unique method of action (MOA) in treating patients with IBS-C.

Physician’s Weekly spoke with a panel of experts in hepatology and oncology to discuss the role of two treatment guidelines in the management HCC.

Physician’s Weekly recently spoke with William D. Chey, MD, FACG, AGAF, FACP, RFF, the lead author...

Physician’s Weekly recently spoke with Brian E. Lacy, MD, PhD,  a board-certified...